<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id><journal-id journal-id-type="pmc">ploscomp</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Computational Biology</journal-title></journal-title-group><issn pub-type="ppub">1553-734X</issn><issn pub-type="epub">1553-7358</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PCOMPBIOL-D-10-00330</article-id><article-id pub-id-type="doi">10.1371/journal.pcbi.1002272</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Computational biology</subject>
            <subj-group>
              <subject>Systems biology</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Mathematics</subject>
          <subj-group>
            <subject>Applied mathematics</subject>
          </subj-group>
          <subj-group>
            <subject>Nonlinear dynamics</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Computational Biology</subject>
          <subject>Mathematics</subject>
        </subj-group>
      </article-categories><title-group><article-title>A Whole-Body Model for Glycogen Regulation Reveals a Critical Role for Substrate Cycling in Maintaining Blood Glucose Homeostasis</article-title><alt-title alt-title-type="running-head">A Whole-Body Model for Glycogen Regulation</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Xu</surname>
            <given-names>Ke</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Morgan</surname>
            <given-names>Kevin T.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Todd Gehris</surname>
            <given-names>Abby</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Elston</surname>
            <given-names>Timothy C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Gomez</surname>
            <given-names>Shawn M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Biomedical Engineering, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Old Dogs in Training, Carrboro, North Carolina, United States of America</addr-line>       </aff><aff id="aff4"><label>4</label><addr-line>Department of Mathematics, Broome Community College, Binghamton, New York, United States of America</addr-line>       </aff><aff id="aff5"><label>5</label><addr-line>Department of Computer Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America</addr-line>       </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Price</surname>
            <given-names>Nathan D.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">Institute for Systems Biology, United States of America</aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">telston@amath.unc.edu</email> (TCE); <email xlink:type="simple">smgomez@unc.edu</email> (SMG)</corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: KX KTM ATG TCE SMG. Performed the experiments: KX ATG. Analyzed the data: KX KTM ATG TCE SMG. Contributed reagents/materials/analysis tools: KX KTM ATG TCE SMG. Wrote the paper: KX KTM TCE SMG.</p>
        </fn>
      <fn fn-type="conflict">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="collection">
        <month>12</month>
        <year>2011</year>
      </pub-date><pub-date pub-type="epub">
        <day>1</day>
        <month>12</month>
        <year>2011</year>
      </pub-date><volume>7</volume><issue>12</issue><elocation-id>e1002272</elocation-id><history>
        <date date-type="received">
          <day>22</day>
          <month>11</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>9</month>
          <year>2011</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2011</copyright-year><copyright-holder>Xu et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
        <p>Timely, and sometimes rapid, metabolic adaptation to changes in food supply is critical for survival as an organism moves from the fasted to the fed state, and vice versa. These transitions necessitate major metabolic changes to maintain energy homeostasis as the source of blood glucose moves away from ingested carbohydrates, through hepatic glycogen stores, towards gluconeogenesis. The integration of hepatic glycogen regulation with extra-hepatic energetics is a key aspect of these adaptive mechanisms. Here we use computational modeling to explore hepatic glycogen regulation under fed and fasting conditions in the context of a whole-body model. The model was validated against previous experimental results concerning glycogen phosphorylase a (active) and glycogen synthase a dynamics. The model qualitatively reproduced physiological changes that occur during transition from the fed to the fasted state. Analysis of the model reveals a critical role for the inhibition of glycogen synthase phosphatase by glycogen phosphorylase a. This negative regulation leads to high levels of glycogen synthase activity during fasting conditions, which in turn increases substrate (futile) cycling, priming the system for a rapid response once an external source of glucose is restored. This work demonstrates that a mechanistic understanding of the design principles used by metabolic control circuits to maintain homeostasis can benefit from the incorporation of mathematical descriptions of these networks into “whole-body” contextual models that mimic <italic>in vivo</italic> conditions.</p>
      </abstract><abstract abstract-type="summary">
        <title>Author Summary</title>
        <p>Homeostasis of blood glucose concentrations during circadian shifts in survival-related activities, sleep and food availability is crucial for the survival of mammals. This process depends upon glucose intake, short-term storage as glycogen, and gluconeogenesis. The integration of hepatic glycogen anabolic and catabolic dynamics with whole body energetics is critical for survival. In this paper we use computational modeling to investigate the potential survival advantage of substrate (futile) cycling of glycogen and glycogen precursors. Our simulations, combined with published experimental results of other researchers, indicate that as the body enters a state of fasting, the activity of enzymes involved in the synthesis of glycogen increases leading to increased substrate cycling. This increase in substrate cycling allows the system to respond more rapidly once new external sources of glucose become available. The whole-body computational model developed for this work allows the metabolic control circuitry to be studied under simulated in vivo conditions, providing functional insights that are not evident when individual modules of glycogen regulatory circuitry are examined in isolation.</p>
      </abstract><funding-group><funding-statement>Financial support for these studies was provided, in part, by the United States Environmental Protection Agency grant (RD833825). However, the research described in this article has not been subjected to the Agency's peer review and policy review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
        <page-count count="13"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Glucose is the major metabolic fuel of mammals, with its maintenance at appropriate levels within the body being crucial for normal function, while dysregulation is associated with diseases such as diabetes mellitus, galactosemia and glycogen storage diseases <xref ref-type="bibr" rid="pcbi.1002272-Devlin1">[1]</xref>. Maintaining glucose levels requires a highly responsive control system capable of balancing a wide range of environmental conditions, perhaps the most basic of which is managing the uptake of nutrients from food at irregular time intervals. Specifically, transitions between fed and fasted states require rapid shifting between the storage of excess glucose, in the form of glycogen, within the liver and muscle and the breakdown of these stores for delivery of glucose to other organs. In healthy individuals, proper functioning of this system ensures that available nutrients are efficiently captured and stored during times of excess, while effectively managed and distributed during times of fasting.</p>
      <p>The rate with which the organism responds to these changes can play a critical role in survival. Optimization of energy storage is essential during competition for sparse food supplies, while rapid delivery of these energy supplies during hasty retreat from predators can mean the difference between life and death <xref ref-type="bibr" rid="pcbi.1002272-Parsons1">[2]</xref>. A key player in energetics, especially for erythrocyte and brain function, is blood glucose concentration.</p>
      <p>The liver is the central organ for regulation of glucose and glycogen and acts as the primary distributor of nutrients through the blood to other tissues. When in a fasted state, the liver breaks down glycogen stores, producing glucose for other tissues. After a meal, the liver switches to a glucose consuming state, capturing nearly 26% of the glucose presented to it by the portal system during the first passage <xref ref-type="bibr" rid="pcbi.1002272-Pardridge1">[3]</xref>. Nearly 10–15% <xref ref-type="bibr" rid="pcbi.1002272-Otter1">[4]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Bonjorn1">[5]</xref> of liver weight is comprised of glycogen stores when filled.</p>
      <p>Glucose regulation within the liver is performed by the glycogen circuit that controls both the storage of glucose as glycogen (glycogenesis) as well as its breakdown into glucose-6-phosphate from hepatic stores (glycogenolysis). Of significance is the fact that glycogenolysis and glycogenesis are not the result of a single reversible reaction, but rather are two separate, highly-regulated pathways. Two key molecular players within these pathways are glycogen synthase (GS) and glycogen phosphorylase (GP). GS drives the synthesis of glycogen, with its activity regulated through multiple mechanisms including allosteric activation, covalent modification, as well as enzymatic translocation <xref ref-type="bibr" rid="pcbi.1002272-Roach1">[6]</xref>–<xref ref-type="bibr" rid="pcbi.1002272-Greenberg1">[8]</xref>. GP catalyzes the rate-limiting step in glycogenolysis and it too, is actively regulated through phosphorylation at a single residue on the NH2 terminus as well as through allosteric regulation <xref ref-type="bibr" rid="pcbi.1002272-Roach1">[6]</xref>–<xref ref-type="bibr" rid="pcbi.1002272-Greenberg1">[8]</xref>. Both these enzymes exist in activated (GSa and GPa) as well as inactivated (GSb and GPb) states.</p>
      <p>As the synthesis of glycogen and its breakdown into glucose occur through separate pathways, there is the potential for substrate cycling to occur, wherein glucose and glycogen are continuously interconverted. In fact, the glycogen circuit exhibits different behaviors depending on the state of liver glycogen levels (<xref ref-type="fig" rid="pcbi-1002272-g001">Figure 1</xref>). In the fed state, glucose is plentiful in the blood and glycogen levels within the liver are relatively high, resulting in the activation of GS and the synthesis of glycogen. When a fasting state is entered, glycogen levels in the liver are high and blood glucose levels are maintained by the breakdown of this glycogen into glucose-6-phosphate by GPa. Finally, when in the fully fasted state, glycogen stores within the liver are essentially depleted. It is here, in the context of glycogen depletion, that cycling is observed between glycogen and glycose-6-phosphate <xref ref-type="bibr" rid="pcbi.1002272-Roden1">[9]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Hers2">[10]</xref>.</p>
      <fig id="pcbi-1002272-g001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1002272.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Liver glycogen levels control circuit architecture.</title>
          <p>Glycogen is synthesized by GSa and broken down into glucose-6-phosphate by GPa. Glycogen levels within the liver are shown in the Fed, Fasting and Fasted state as shaded boxes, with full liver glycogen stores being shown as a solid black box in the Fed portion of the circuit. Arrows indicate which branch of the pathway is active. Substrate cycling occurs in the glycogen-depleted (empty box), Fasted state.</p>
        </caption>
        <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.g001" xlink:type="simple"/>
      </fig>
      <p>It has long been suggested that substrate cycling is a generic mechanism that can potentially improve such properties as sensitivity and system response time, allowing net synthesis when there is a small offset in the substrate concentrations <xref ref-type="bibr" rid="pcbi.1002272-Hers1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Hers2">[10]</xref>–<xref ref-type="bibr" rid="pcbi.1002272-Chao1">[13]</xref>. However, demonstrations of cycling and its functional relevance in a physiological context are still relatively rare. In this work, we were particularly interested in investigating the potential role of the cycling - no cycling architecture of the glycogen circuit manifested during the transition from a fed to a fasted state. While the benefit of preventing substrate cycling is apparent since energy is dissipated in the form of heat during this process, it is not clear why it is beneficial for glycogen to cycle under the fasted state, as shown in <xref ref-type="fig" rid="pcbi-1002272-g001">Figure 1</xref>.</p>
      <p>Mathematical models, which provide one way to explore such questions, have been applied successfully to many biological fields, but their application has been limited in the case of the nutritional sciences <xref ref-type="bibr" rid="pcbi.1002272-deGraaf1">[14]</xref>. The number of mathematical models of hepatic energy metabolism, as it relates to hepatic glycogen storage, has been slowly increasing in response to interest in the impact of exercise on energetics in the case of diabetes <xref ref-type="bibr" rid="pcbi.1002272-deGraaf1">[14]</xref>, diet <xref ref-type="bibr" rid="pcbi.1002272-Hall1">[15]</xref> and athletic training <xref ref-type="bibr" rid="pcbi.1002272-Gastin1">[16]</xref>. In addition, large-scale reconstructions of metabolism, typically based on flux or constraint-based models, have recently been developed for multiple organ systems including the liver <xref ref-type="bibr" rid="pcbi.1002272-Duarte1">[17]</xref>–<xref ref-type="bibr" rid="pcbi.1002272-Maier1">[21]</xref>. These stochiometry-based approaches can be used to analyze the relevant biological network solely based upon systemic mass-balance and reaction capacity constraints when kinetic information is missing <xref ref-type="bibr" rid="pcbi.1002272-Edwards1">[22]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Orth1">[23]</xref>. However, as these approaches are based on steady state assumptions and do not consider specific kinetic properties, they provide a fundamentally different view of metabolism and metabolic dynamics than detailed mechanistic models.</p>
      <p>In the absence of a suitable model for the present work, we developed a physiological model based on a central control glycogen circuitry by Hers et al. <xref ref-type="bibr" rid="pcbi.1002272-Hers1">[7]</xref> and Mutalik et al. <xref ref-type="bibr" rid="pcbi.1002272-Mutalik1">[24]</xref>, with the whole body bioenergetics described in <xref ref-type="bibr" rid="pcbi.1002272-Roden2">[25]</xref>–<xref ref-type="bibr" rid="pcbi.1002272-Frayn1">[29]</xref> as well as the feedback and feed forward control loops described in <xref ref-type="bibr" rid="pcbi.1002272-Alon1">[30]</xref>–<xref ref-type="bibr" rid="pcbi.1002272-Lahav1">[33]</xref> for maintaining glucose homeostasis under different fed-fasting conditions. We placed specific emphasis on investigating the role of the cycling - no cycling architecture in metabolic functions. Building on previous biochemical and quantitative modeling descriptions, this model embedded the glycogen circuit of the liver within a physiological system composed of muscle, adipose tissue and blood compartments. By controlling the glucose injection rate into the blood stream, we were able to simulate system response across a broad range of fed/fasting conditions. Our simulation results reproduced previously published experimental observations and further indicated that the cycling design in <xref ref-type="fig" rid="pcbi-1002272-g001">Figure 1</xref> provides a mechanism for decreasing the amount of time it takes to convert glucose to glycogen in the fasted state.</p>
    </sec>
    <sec id="s2">
      <title>Results/Discussion</title>
      <sec id="s2a">
        <title>Model overview</title>
        <p>We now give a brief overview of our model, with full details and the complete set of model equations provided in <xref ref-type="supplementary-material" rid="pcbi.1002272.s001">Protocol S1</xref>. Note that the complete MATLAB package together with the description file are provided in <xref ref-type="supplementary-material" rid="pcbi.1002272.s002">Protocol S2</xref> and <xref ref-type="supplementary-material" rid="pcbi.1002272.s003">S3</xref>, respectively. The SBML code is also provided in <xref ref-type="supplementary-material" rid="pcbi.1002272.s004">Protocol S4</xref> for a broader usage and implementation. As noted earlier, glycogen is created from glucose during feeding and is subsequently degraded to release glucose-6-phosphate during fasting. The hepatic glycogen circuit controlling this process is embedded within the hepatocyte at the center of our physiological model (<xref ref-type="fig" rid="pcbi-1002272-g002">Figure 2</xref>). Blood is depicted as a closed loop, being carried around the body to connect multiple tissue compartments, including the liver, muscle, and fat. Thus blood functions as a transport system within our model, providing the resources needed to manufacture and store hepatic glycogen during the fed state while carrying its major degradation product, glucose, away during the fasted state for use by other tissues. The liver is currently the most detailed compartment in this model, including selected aspects of glycogenolysis, glycogenesis, glycolysis, gluconeogenesis, the TCA cycle, lipogenesis, lipolysis and ketogenesis (See <xref ref-type="supplementary-material" rid="pcbi.1002272.s001">Protocol S1</xref> for model equations).</p>
        <fig id="pcbi-1002272-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002272.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Diagrammatic representation of key features of the physiological model.</title>
            <p>The general design principles of the model are based on established bioenergetic physiology <xref ref-type="bibr" rid="pcbi.1002272-Devlin1">[1]</xref>. The liver, placed at the center of this diagrammatic representation of “the body”, contains the glycogen circuitry which lies within hepatocytes connected to other organs by the vascular system (show in red). Blood within the vascular system travels around the body, carrying materials between the liver and other organs, with a cycle time of about one minute. Key: Gluc = glucose; FFA = free fatty acids; Ket = ketones; TAG = triacylglycerol; ACoA = acetyl CoA; Alan = alanine. Note that kidney, brain and erythrocytes are not included in the current model.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.g002" xlink:type="simple"/>
        </fig>
        <p>As an animal moves through the fed, fasting and fasted states, its body switches to different types of metabolic fuels to stabilize blood glucose concentration. This transition is controlled in large part by the blood levels of insulin and glucagon, both of which are generated in a reciprocal manner by the pancreas in response to changing blood glucose levels. Insulin and glucagon are mutually antagonistic with respect to many aspects of intermediary metabolism and their effects on bioenergetics <xref ref-type="bibr" rid="pcbi.1002272-Roden2">[25]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Klover1">[34]</xref>. Insulin is a key regulator for carbohydrate and fat metabolism in the body. It enhances blood glucose uptake to form triglycerides and glycogen and suppresses pathways such as gluconeogensis and glycogenolysis <xref ref-type="bibr" rid="pcbi.1002272-Khan1">[35]</xref>. Glucagon, on the other hand, is secreted from the pancreas when blood glucose concentration is low. It inhibits glycolysis and stimulates hepatic glycogenolysis and gluconeogenesis in liver by increasing the concentration of cAMP <xref ref-type="bibr" rid="pcbi.1002272-Jiang1">[36]</xref>. The elevated level of cAMP in turn activates a cascade of enzymes in the glycogen control circuitry that enhance the degradation of glycogen molecules <xref ref-type="bibr" rid="pcbi.1002272-Hers1">[7]</xref>. Insulin and glucagon, working in a reciprocal fashion, in conjunction with other hormonal regulators, such as leptin and epinephrine, maintain glucose homeostasis in biological systems. Our physiological model also incorporates aspects of the Cori cycle, where lactate from muscle and erythrocytes is carried to the liver and converted to glucose for reuse by these tissues.</p>
        <p>Blood glucose is provided from absorbed carbohydrates during feeding up until digestion is complete, at which point hepatic glycogen stores take over this role. Depletion of hepatic glycogen occurs over a period of 12–24 hours, though this varies greatly with activity levels <xref ref-type="bibr" rid="pcbi.1002272-Hers1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Dohm1">[37]</xref>. Once hepatic glycogen stores are consumed, blood glucose levels are maintained by gluconeogenesis. This process uses energy derived from storage fat in the form of acetyl CoA and the carbon skeletons of glycogenic amino acids. In the present physiological model, glycogenic amino acids are represented by alanine derived from muscle. The major sites of gluconeogenesis are the kidney and the liver, with only the latter being represented here. As blood glucose levels fall due to hepatic glycogen depletion, blood insulin levels fall while glucagon levels rise, leading to biochemical changes resulting in the use of alternative fuels in the form of free fatty acids and ketones, and gluconeogenesis which requires the use of such energy as mentioned above.</p>
        <p>In tissues such as the heart and muscle, a number of factors regulate the use of alternative energy sources in order to spare blood glucose for use by erythrocytes (which depends solely on blood glucose <xref ref-type="bibr" rid="pcbi.1002272-Wijk1">[38]</xref>) and the brain (which mainly depends on blood glucose but can use ketone bodies as an alternative during fasting <xref ref-type="bibr" rid="pcbi.1002272-Magistretti1">[39]</xref>). Our general bioenergetic model includes a number of tissue and biochemical components that were selected on the basis of their relationship to glycogen metabolism. The timing of these events and the dynamics of blood insulin, glucagon, glucose, free fatty acids, ketones, and levels of hepatic glycogen stores in response to fasting and feeding cycles from our simulation are shown in <xref ref-type="fig" rid="pcbi-1002272-g003">Figure 3</xref> and are consistent with those which were previously described in <xref ref-type="bibr" rid="pcbi.1002272-Roden2">[25]</xref>–<xref ref-type="bibr" rid="pcbi.1002272-Frayn1">[29]</xref>.</p>
        <fig id="pcbi-1002272-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002272.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Simulation results: dynamic responses of selected hormones and substrates during a 24-hour fasting period.</title>
            <p>Note that hormone and substrate concentrations are normalized by their maximum values during the simulation. Blood glucose concentration has a multiplier of 0.8 to give a better view. Key: bl gluc = blood glucose; pl glucagon = plasma glucagon; pl ins = plasma insulin; pl FFA = plasma free fatty acids; bl ket = blood ketone bodies.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.g003" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s2b">
        <title>The cyclic-AMP (cAMP) induced glucose-glycogen circuitry</title>
        <sec id="s2b1">
          <title>Internal cues: cAMP activates a cascade of enzymes</title>
          <p>The glycogen circuitry is activated by intra- and extracellular signals including cAMP, glucose and glucose-6-phosphate. As blood glucose begins to fall in the post-absorptive state, glucagon is secreted from the pancreas and causes elevation of cAMP levels <xref ref-type="bibr" rid="pcbi.1002272-Jiang1">[36]</xref>. The increase in cAMP signal leads to activation of cAMP-dependent protein kinase (CAPK), which in turn activates phosphorylase kinase (PK). PK phosphorylates GS (less active, b-form) and GP (more active, a-form) and drives the system to enter a catabolic state where glycogen molecules are broken down to supply liver glucose output and maintain blood glucose levels. Note that GP can be inhibited directly by high levels of glucose <xref ref-type="bibr" rid="pcbi.1002272-Hers2">[10]</xref> as indicated in <xref ref-type="fig" rid="pcbi-1002272-g004">Figure 4</xref>. Protein phosphatase-1 (PP-1) is another key element in this regulation, acting as the primary phosphatase catalyzing the dephosphorylation of PK, GP, and GS. A variety of evidence shows that GPa has an inhibitory effect on the dephosphorylation (activation) of GS under fed conditions <xref ref-type="bibr" rid="pcbi.1002272-Hers1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Stalmans1">[40]</xref>, as shown on the bottom of <xref ref-type="fig" rid="pcbi-1002272-g004">Figure 4</xref>. This inhibition is mediated by the direct binding of GPa to glycogen synthase phosphatase (GS phosphatase), a major enzyme catalyzing the conversion of GS from the D (b - phosphorylated, less active) to the I (a - unphosphorylated, active) form. To model this inhibitory effect, we incorporated the dissociation constant (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e001" xlink:type="simple"/></inline-formula>) between GPa and GS phosphotase, as first proposed by Mutalik et al. <xref ref-type="bibr" rid="pcbi.1002272-Mutalik1">[24]</xref>. As a whole, the intracellular cAMP concentration determines the level of activated kinases and phosphatases within the cell, which in turn determines the levels of GPa and GSa and therefore the glycogen degradation and synthesis rates <xref ref-type="bibr" rid="pcbi.1002272-Hers1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Mutalik1">[24]</xref>.</p>
          <fig id="pcbi-1002272-g004" position="float">
            <object-id pub-id-type="doi">10.1371/journal.pcbi.1002272.g004</object-id>
            <label>Figure 4</label>
            <caption>
              <title>The central control glycogen circuitry (modified from Figure 3.1 in <xref ref-type="bibr" rid="pcbi.1002272-Todd1">[<bold>43</bold>]</xref>).</title>
              <p>Rectangles and circles enclose the names or abbreviations of enzymes and substrates accordingly. The reactions as a result of an increase in cAMP concentrations are shown with bold arrows. cAMP = cyclic adenosine monophosphate; R2C2 = cAMP dependent protein kinase; C = R2C2 catalytic subunit; PKb = inactive phosphorylase kinase; PKa = active phosphorylase kinase; GPb = inactive glycogen phosphorylase; GPa = active glycogen phosphorylase; GSb = inactive glycogen phosphorylase; GSb = inactive glycogen synthase; GSa = active glycogen synthase; P = phosphate; g-6-p = glucose-6-phosphate; PP1, protein phosphatase-1.</p>
            </caption>
            <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.g004" xlink:type="simple"/>
          </fig>
          <p>As mentioned above, GPa inactivates GS phosphatase by direct binding under the fed condition. In fact, Stalmans et al. <xref ref-type="bibr" rid="pcbi.1002272-Stalmans1">[40]</xref> observed that only after the levels of GPa dropped below 10% of the total enzyme (a+b) would liver GS then be activated. It has also been shown that the inhibition of GS phosphatase by GPa depends on liver glycogen concentration and that a minimal amount of glycogen is required for this inhibition <xref ref-type="bibr" rid="pcbi.1002272-Massillon1">[41]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Mvumbi1">[42]</xref>. Therefore, the level of inhibition of GS phosphatase by GPa is highly dependent on both the activation state induced by external glucose and hormonal cues, as well as the internal state of liver glycogen stores (indicated by a red arrow in <xref ref-type="fig" rid="pcbi-1002272-g004">Figure 4</xref>). Since this inhibition is induced by direct binding of GPa to GS phosphatase, one way to model the difference in inhibition is through the dissociation constant (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e002" xlink:type="simple"/></inline-formula>) of these two enzymes, as first proposed by Mutalik et al. <xref ref-type="bibr" rid="pcbi.1002272-Mutalik1">[24]</xref>. Note that in their work, a <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e003" xlink:type="simple"/></inline-formula> of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e004" xlink:type="simple"/></inline-formula> was set to correspond to a fasted state while a <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e005" xlink:type="simple"/></inline-formula> of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e006" xlink:type="simple"/></inline-formula> corresponded to a fed state. As described further below, we similarly use the dissociation constant of GS phosphatase and GPa as a means to model the discrepancy in the enzymatic activities in fed and fasting states. For a detailed discussion, we refer the readers to <xref ref-type="bibr" rid="pcbi.1002272-Mutalik1">[24]</xref>.</p>
        </sec>
        <sec id="s2b2">
          <title>External cues: Insulin, glucagon and cAMP</title>
          <p>Insulin and glucagon are two key hormones that both regulate, and are regulated by, blood glucose concentration. The concentrations of these two hormones are governed by the equations <xref ref-type="bibr" rid="pcbi.1002272-Todd1">[43]</xref>:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e007" xlink:type="simple"/><label>(1)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e008" xlink:type="simple"/><label>(2)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e009" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e010" xlink:type="simple"/></inline-formula> are the basal secretion rates and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e011" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e012" xlink:type="simple"/></inline-formula> are the degradation rates for insulin and glucagon, respectively. We assume that the release rate of insulin into the blood increases with glucose levels according to Hill kinetics with a Hill coefficient of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e013" xlink:type="simple"/></inline-formula>. The maximal insulin-induced release rate is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e014" xlink:type="simple"/></inline-formula> and the glucose concentration at which this rate is half its maximum is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e015" xlink:type="simple"/></inline-formula>. Similarly, to model the decrease in glucagon at high blood glucose levels, we assume the release rate of glucagon decreases according to Hill kinetics. The Hill coefficient is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e016" xlink:type="simple"/></inline-formula>, the maximum induced release rate is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e017" xlink:type="simple"/></inline-formula>, and the glucose concentration at which the release rate is half its maximum is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e018" xlink:type="simple"/></inline-formula>. The values of the parameters in the above two equations are chosen such that the concentrations of insulin and glucagon are in the range of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e019" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e020" xlink:type="simple"/></inline-formula>, taken from physiologically relevant ranges determined from rodent studies <xref ref-type="bibr" rid="pcbi.1002272-Balks1">[27]</xref>.</p>
          <p>cAMP is a secondary messenger that is regulated by both insulin and glucagon. Following a drop in blood glucose levels, cAMP activates CAPK according to the following reaction:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e021" xlink:type="simple"/><label>(3)</label></disp-formula>The above reaction includes two steps and results in the release of 2 molecules of catalytic subunit C from CAPK by 4 molecules of cAMP. The equation that governs the concentration of cAMP is then <xref ref-type="bibr" rid="pcbi.1002272-Todd1">[43]</xref>:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e022" xlink:type="simple"/><label>(4)</label></disp-formula>where we assume Michaelis-Menten type kinetics for the regulatory functions of insulin and glucagon on cAMP. The two Michaelis-Menten constants <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e023" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e024" xlink:type="simple"/></inline-formula> were set to be the mean values of the glucagon and insulin concentrations, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e025" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e026" xlink:type="simple"/></inline-formula>, respectively, while the parameters involved in the activation of CAPK are adopted from <xref ref-type="bibr" rid="pcbi.1002272-Mutalik1">[24]</xref>.</p>
          <p>The amount of the catalytic subunit C determines the activity level of GP and GS <xref ref-type="bibr" rid="pcbi.1002272-Hers1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Mutalik1">[24]</xref>. Together, these two enzymes regulate the metabolism of liver glycogen: if GS is more active, the system converts excessive glucose into glycogen for short-term storage; if GP is mostly active, the system utilizes glycogen to make glucose to supply the needs of other organs. The equation for the glycogen concentration is <xref ref-type="bibr" rid="pcbi.1002272-Todd1">[43]</xref>:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e027" xlink:type="simple"/><label>(5)</label></disp-formula>where again we use Michaelis-Menten kinetics to describe the enzymatic activities.</p>
          <p>Finally, the glucose concentrations in liver <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e028" xlink:type="simple"/></inline-formula> and blood <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e029" xlink:type="simple"/></inline-formula> are given in Equations (6) and (7) correspondingly <xref ref-type="bibr" rid="pcbi.1002272-Todd1">[43]</xref>, where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e030" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e031" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e032" xlink:type="simple"/></inline-formula> are the glucose transport rates from the blood stream to liver, adipose tissue and muscle, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e033" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e034" xlink:type="simple"/></inline-formula> are the reaction rates for the conversion of glucose into g6p and g6p back to glucose, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e035" xlink:type="simple"/></inline-formula> is the degradation rate of blood glucose and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e036" xlink:type="simple"/></inline-formula> is the feeding function for blood glucose, which is subject to change under different feeding patterns.<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e037" xlink:type="simple"/><label>(6)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e038" xlink:type="simple"/><label>(7)</label></disp-formula></p>
        </sec>
      </sec>
      <sec id="s2c">
        <title>The degree of substrate cycling depends upon the dissociation constant <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e039" xlink:type="simple"/></inline-formula></title>
        <p>Mutalik and Venkatesh <xref ref-type="bibr" rid="pcbi.1002272-Mutalik1">[24]</xref> computed the dose response curves of the enzymes in the glycogen circuitry based on their empirically derived input functions for glucose-6-phosphate (G6p) and cAMP. Again, we note that the dissociation constant (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e040" xlink:type="simple"/></inline-formula>) of GS phosphatase and GPa is the key factor in determining the amount of substrate cycling at steady state. In fact, Mutalik et al. <xref ref-type="bibr" rid="pcbi.1002272-Mutalik1">[24]</xref> defined different physiological states based on the value of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e041" xlink:type="simple"/></inline-formula>, where a smaller value (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e042" xlink:type="simple"/></inline-formula>) corresponded to a fed state and a larger one (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e043" xlink:type="simple"/></inline-formula>) corresponded to a fasted state. We followed a similar approach to construct the dose response curves for these enzymes. Unlike <xref ref-type="bibr" rid="pcbi.1002272-Mutalik1">[24]</xref>, the glycogen circuitry was incorporated into a 4-compartment physiological model. As a result, the dynamics of cAMP and glucose-6-phosphate were simulated directly within our model and the entire system can be more realistically simulated by simply controlling the plasma glucose concentration.</p>
        <p>The dose-response curves for GSa and GPa at two specified values of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e044" xlink:type="simple"/></inline-formula> are shown in <xref ref-type="fig" rid="pcbi-1002272-g005">Figure 5</xref>. Here, the system was run to steady state with a fixed blood glucose concentration between 5 mM and 10 mM, the typical range for fed-fasting experiments in rodents <xref ref-type="bibr" rid="pcbi.1002272-Balks1">[27]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Kelsall1">[44]</xref>–<xref ref-type="bibr" rid="pcbi.1002272-Klueh1">[46]</xref>. By increasing the <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e045" xlink:type="simple"/></inline-formula> constant from <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e046" xlink:type="simple"/></inline-formula> to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e047" xlink:type="simple"/></inline-formula>, the crossover point of GPa and GSa shifted from a higher glucose concentration to a lower one (from <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e048" xlink:type="simple"/></inline-formula> to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e049" xlink:type="simple"/></inline-formula>) with a correspondingly higher activated fraction (from 5% to 60%). This fraction represents the maximum percentage of both enzymes being active simultaneously, thus it is an indicator of the degree of substrate cycling in the system. We note that the inhibitory effect by GPa on the activation of GS through direct binding to GS phosphatase is partially released with a larger <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e050" xlink:type="simple"/></inline-formula>.</p>
        <fig id="pcbi-1002272-g005" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002272.g005</object-id>
          <label>Figure 5</label>
          <caption>
            <title>Fractional activation of GPa and GSa plotted against blood glucose concentration under two selected </title>
            <p><inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e051" xlink:type="simple"/></inline-formula><bold>.</bold> A: <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e052" xlink:type="simple"/></inline-formula> corresponds to a stronger binding between glycogen phosphorylase a (GPa) and GS phosphatase, which results in a strong inhibition on the activation of glycogen synthase (GSa). B: <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e053" xlink:type="simple"/></inline-formula> corresponds to a weaker binding between GPa and GS phosphatase, where the inhibition by GPa is partially relieved.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.g005" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s2d">
        <title>The response time for glycogen synthesis decreases with a larger value of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e054" xlink:type="simple"/></inline-formula> in the glycogen depleted state</title>
        <p>From the above discussion, it is apparent that the inhibition of GS activation by GPa through direct regulation of GS phosphatase varies with the state of fasting. With a larger <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e055" xlink:type="simple"/></inline-formula>, the maximum amount of substrate cycling (co-activated fraction of GS and GP) is higher at the steady state. Here, we further investigated the dynamics of GS and GP but in the context of a glycogen depleted liver.</p>
        <p>To simulate the response of the system to glucose in a glycogen depleted state, we provided a constant input of glucose with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e056" xlink:type="simple"/></inline-formula> and ran the simulation to steady state. We then gradually throttled back the glucose input, and waited until liver glycogen was completely depleted. Glucose supply then re-entered the blood stream as a step function at t = 0, after which the dynamics of hormone, enzyme and substrate responses were observed. The results for two values of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e057" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e058" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e059" xlink:type="simple"/></inline-formula> are shown in <xref ref-type="fig" rid="pcbi-1002272-g006">Figure 6A</xref>. Note that the observation period began at <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e060" xlink:type="simple"/></inline-formula>. A detailed description of the plasma glucose feeding function <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e061" xlink:type="simple"/></inline-formula> is provided in Figure S5 in <xref ref-type="supplementary-material" rid="pcbi.1002272.s001">Protocol S1</xref>.</p>
        <fig id="pcbi-1002272-g006" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002272.g006</object-id>
          <label>Figure 6</label>
          <caption>
            <title>Time evolutions curves of selected enzymes and substrates.</title>
            <p>A: Time response curves of GSa and GPa under two selected <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e062" xlink:type="simple"/></inline-formula> after glucose stimulus enters blood stream at <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e063" xlink:type="simple"/></inline-formula> in a glycogen depleted liver. Crossover of GSa and GPa occurs at 13.4 and 30.6 minutes respectively. B: Liver glycogen concentration plotted against time under the two selected <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e064" xlink:type="simple"/></inline-formula>.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.g006" xlink:type="simple"/>
        </fig>
        <p><xref ref-type="fig" rid="pcbi-1002272-g006">Figures 6A–B</xref> show selected enzyme activities and glycogen concentration as a function of time. Note that “glycogen concentration” here and in the later context refers to the amount of glucose converted to glycogen as one molecule of glycogen comprises an indeterminate number (hundreds or thousands) of glucose subunits. At <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e065" xlink:type="simple"/></inline-formula>, liver glycogen stores are completely depleted and GP is mostly active (over 70% in the <italic>a</italic>-form). The sudden increase in the blood glucose concentration drove the transition from a GP-dominant to GS-dominant scenario. There was a major difference in when and where the intersection of GPa and GSa activity curves occurred for the two selected values of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e066" xlink:type="simple"/></inline-formula>. Under <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e067" xlink:type="simple"/></inline-formula>, the point of intersection occurred at 60% and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e068" xlink:type="simple"/></inline-formula> (<xref ref-type="fig" rid="pcbi-1002272-g006">Figure 6A-left panel</xref>). In contrast, this point shifted to 5% and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e069" xlink:type="simple"/></inline-formula> with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e070" xlink:type="simple"/></inline-formula> <xref ref-type="fig" rid="pcbi-1002272-g006">Figure 6B-right panel</xref>.</p>
        <p><xref ref-type="fig" rid="pcbi-1002272-g006">Figure 6B</xref> showed the liver glycogen concentration as a function of time. Again, the observations started at <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e071" xlink:type="simple"/></inline-formula> where the blood glucose supply resumed. Readily apparent was the slow but nearly immediate increase in the glycogen concentration at <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e072" xlink:type="simple"/></inline-formula> under <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e073" xlink:type="simple"/></inline-formula> (black line with dots). Recall that at this value, the level of inhibition of GS phosphatase by GPa was much reduced, allowing the coexistence of 60% of GSa and GPa. In contrast, the liver glycogen concentration remained at a negligible level until <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e074" xlink:type="simple"/></inline-formula> with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e075" xlink:type="simple"/></inline-formula> (solid line with squares) where substrate cycling was reduced to 5%. Therefore, the system was able to respond quickly to the glucose stimulus and drive an immediate synthesis of glycogen with a higher level of substrate cycling. In both cases, a dramatic change in the synthesis rate of glycogen occurred where GSa and GPa intersect (15 mins and 30.6 mins correspondingly).</p>
        <p>We next further investigated the relationship between the system response time and the level of substrate cycling in a glycogen depleted liver. Instead of two values of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e076" xlink:type="simple"/></inline-formula> (marked by a red square (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e077" xlink:type="simple"/></inline-formula>) and triangle (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e078" xlink:type="simple"/></inline-formula>) in <xref ref-type="fig" rid="pcbi-1002272-g007">Figure 7</xref>), we considered a range of values from <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e079" xlink:type="simple"/></inline-formula> to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e080" xlink:type="simple"/></inline-formula>. There are two different ways to define the system response time to glucose stimulus: (1) the time when the GSa and GPa curves intersect or (2) the time when glycogen concentration exceeds a threshold value. We selected a threshold value of 0.5 mM, the glycogen concentration reached at the end of the simulation (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e081" xlink:type="simple"/></inline-formula>) with the smallest <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e082" xlink:type="simple"/></inline-formula>. The time response curves under both definitions were shown in <xref ref-type="fig" rid="pcbi-1002272-g007">Figure 7A</xref> as a blue and black line respectively. The differences in the response time shown on both curves were on the order of 30 mins between the largest and smallest <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e083" xlink:type="simple"/></inline-formula>. In <xref ref-type="fig" rid="pcbi-1002272-g007">Figure 7B</xref>, we provided the co-active percentage of GS and GP at the intersection point.</p>
        <fig id="pcbi-1002272-g007" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002272.g007</object-id>
          <label>Figure 7</label>
          <caption>
            <title>Enzymes and substrate responses over a series of </title>
            <p><inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e084" xlink:type="simple"/></inline-formula><bold> ranging from </bold><inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e085" xlink:type="simple"/></inline-formula><bold> to </bold><inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e086" xlink:type="simple"/></inline-formula><bold>.</bold> A: System response time to glucose stimulus plotted against <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e087" xlink:type="simple"/></inline-formula> in a glycogen depleted liver. Blue: system response time defined by the cross-over point of glycogen synthase a (GSa) and glycogen phosphorylase a (GPa). Black: system response time defined by the time when liver glycogen concentration exceeds 0.5 mM. Note that the difference in system response time is about 30 mins for the lowest and highest values of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e088" xlink:type="simple"/></inline-formula> selected here under both definitions. B: The co-activated percentage of GSa and GPa at the cross-over point as a function of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e089" xlink:type="simple"/></inline-formula>. Note that this percentage represents the maximum co-active percentage of both enzymes, hence it is an indicator of the level of substrate cycling in the system. The points inside the rectangles (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e090" xlink:type="simple"/></inline-formula>) and triangles (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e091" xlink:type="simple"/></inline-formula>) are the two values chosen in <xref ref-type="fig" rid="pcbi-1002272-g006">Figure 6</xref>.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.g007" xlink:type="simple"/>
        </fig>
        <p>The results from this analysis provide a possible explanation as to why the biological system has different metabolic mechanisms (different <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e092" xlink:type="simple"/></inline-formula>) under different fasting states. In a glycogen-depleted state, it is essential to have a highly responsive system, ready for replenishing energy reserves as soon as nutrients become available. Our simulation results clearly showed that the high degree of substrate cycling occurring in the fasted state accelerated the system response in this respect by about 30 minutes, which would be physiologically significant for survival. Conversely, avoiding substrate cycling in a fed state is also desirable from an energy expenditure standpoint, as the combination of reactions involving GS, GP, glucose 1-phosphate uridylytransferase and nucleoside diphosphate kinase result in an ATP consuming reaction (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e093" xlink:type="simple"/></inline-formula>).</p>
      </sec>
      <sec id="s2e">
        <title>Comparison with experiments</title>
        <p>We have shown that the level of inhibition of GS phosphatase by GPa through the dissociation constant <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e094" xlink:type="simple"/></inline-formula>, or equivalently the level of substrate cycling, determined the system response time in a glycogen depleted liver. Previous studies have shown that this inhibition is glycogen dependent <xref ref-type="bibr" rid="pcbi.1002272-Massillon1">[41]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Mvumbi1">[42]</xref>. Watts et al. <xref ref-type="bibr" rid="pcbi.1002272-Watts1">[47]</xref> reported that the GS phosphatase activity decreased in the livers of fasted, fed and gsd/gsd (liver glycogen storage disorder) mice and the addition of glycogen to homogenates of liver from starved rats reduced the glycogen synthase phosphatase activity. More recently, Armstrong et al. <xref ref-type="bibr" rid="pcbi.1002272-Armstrong1">[48]</xref> pointed out that there are unique binding sites for GPa, PP-1 and glycogen in the hepatic glycogen-targeting subunit of protein phosphatase 1 (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e095" xlink:type="simple"/></inline-formula>), a GS phosphatase specific to liver. Therefore, it is reasonable to assume that this inhibitory regulation changes according to the liver glycogen level. We modeled this effect by using the following expression for the dissociation constant <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e096" xlink:type="simple"/></inline-formula>:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e097" xlink:type="simple"/><label>(8)</label></disp-formula>where [glyc] is the liver glycogen concentration, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e098" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e099" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e100" xlink:type="simple"/></inline-formula> and the Hill constant <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e101" xlink:type="simple"/></inline-formula>. Note that the parameters were chosen to match the experimental results of <xref ref-type="bibr" rid="pcbi.1002272-Hue1">[49]</xref> as shown in <xref ref-type="fig" rid="pcbi-1002272-g008">Figure 8</xref>.</p>
        <fig id="pcbi-1002272-g008" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002272.g008</object-id>
          <label>Figure 8</label>
          <caption>
            <title>Previous experimental results by Hue et al.</title>
            <p>Glycogen phosphorylase a (GPa) and glycogen synthase a (GSa) activities in hepatocytes under fed (A) and fasted conditions (B) are redrawn from experimental results by Hue et al. <xref ref-type="bibr" rid="pcbi.1002272-Hue1">[49]</xref>). From left to right, top to bottom in panel A and B: 4 increasing glucose concentrations from 5.5 to 55 mM in the incubation medium caused a sequential inactivation of glycogen phosphorylase and activation of glycogen synthase.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.g008" xlink:type="simple"/>
        </fig>
        <p>We compared our model predictions to experimental studies that investigated GS and GP levels within fed and fasted livers in a rodent model system <xref ref-type="bibr" rid="pcbi.1002272-Hue1">[49]</xref>. In this work, Hue et al. measured GP and GS activities over time in isolated hepatocytes under sequential changes to the glucose concentration (from 5.5 mM to 55 mM) in the incubation medium. Results from this study were redrawn in <xref ref-type="fig" rid="pcbi-1002272-g008">Figure 8</xref>.</p>
        <p>It is important to note that we are comparing a “whole-body” simulation with results obtained from cultured cells which are not interacting with events driven by other tissues, such as fat and muscle. However, this comparison demonstrates clear similarities between these cell culture data and our simulations with respect to responses of the glycogen regulatory circuitry to blood glucose concentrations. We started our simulation at the fed steady state and fasted the model system to two different times, 250 mins and 1200 mins, to represent fed and fasted livers respectively. In the simulation for fed livers, 250 mins fasting time was chosen to recreate a fasting environment as seen at the beginning of the experiments (<xref ref-type="fig" rid="pcbi-1002272-g008">Figure 8A</xref>), where GP is mostly in the active form and over 90% GS is in the inactive form <xref ref-type="bibr" rid="pcbi.1002272-Hue1">[49]</xref>. Note that after 250 mins, the liver glycogen level was at about 75% of the fed steady state. In the simulation for fasted livers, 1200 mins was chosen after which only less than 1% glycogen remained. We then compared the response from both livers under 4 different glucose feeding rates (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e102" xlink:type="simple"/></inline-formula>), as shown in <xref ref-type="fig" rid="pcbi-1002272-g009">Figure 9</xref>. Since we made our observation only after glucose supply re-entered the blood stream, we shifted the simulation time forward to 250 mins and 1200 mins in the fed and fasted livers and denoted them as <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e103" xlink:type="simple"/></inline-formula>.</p>
        <fig id="pcbi-1002272-g009" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002272.g009</object-id>
          <label>Figure 9</label>
          <caption>
            <title>Simulation results by computational modeling (a parallel comparison to <xref ref-type="fig" rid="pcbi-1002272-g008"><bold>Figure 8</bold></xref>).</title>
            <p>Glycogen synthase a (solid circles) and glycogen phosphorylase a (open circles) activities are plotted against time under 4 different glucose input rate in fed (A) and fasted livers (B). From left to right, top to bottom: <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e104" xlink:type="simple"/></inline-formula>. Note that the y-axis is the active to total enzyme percentage.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.g009" xlink:type="simple"/>
        </fig>
        <p>Multiple aspects of our simulation results matched reported experimental observations of <xref ref-type="bibr" rid="pcbi.1002272-Hue1">[49]</xref>. For instance, simulations and experiments showed the activation of GS to be highly suppressed by GPa in the fed state. For the lowest glucose injection rate, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e105" xlink:type="simple"/></inline-formula>, GS is not activated at all, which was also observed in experiments by Hue et al. (<xref ref-type="fig" rid="pcbi-1002272-g008">Figure 8A</xref>). Both the experimental and simulation results showed that the active percentage of GS was higher in the fasted than in the fed state at the end of the experiment/simulation (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002272.e106" xlink:type="simple"/></inline-formula>). Furthermore, in both experimental studies and simulations, GS always responded more rapidly (on the order of 10–15 minutes as defined by the cross-over point of GSa and GPa) in the glycogen-depleted compared to the fed state. As the injection rate of glucose increased, the response time of GSa was shortened. Note that the glycogen concentrations from our simulation are provided in Figure S6 in <xref ref-type="supplementary-material" rid="pcbi.1002272.s001">Protocol S1</xref>, which also indicated a quicker response from the fasted livers. Although we can accurately capture the changes in response time under different glucose concentrations, it is clear that we have only addressed limited aspects of the relevant metabolic pathways and associated regulatory components. For instance, it is known that bioenergetics is regulated by a number of mechanisms including push-pull <xref ref-type="bibr" rid="pcbi.1002272-Cortassa1">[50]</xref> and negative feedback, the latter being an integral component of our whole-body and glycogen-specific models. Furthermore, transcript level regulation is required to capture variations in enzyme concentration that occur under different fasting conditions. Such investigations lie outside the scope of the current model.</p>
      </sec>
      <sec id="s2f">
        <title>Conclusions</title>
        <p>The cells, tissues, organs, bodies and populations of all living organisms are in a constant state of sensing and response to numerous external and self-generated stimuli <xref ref-type="bibr" rid="pcbi.1002272-LeDuc1">[51]</xref>. Feedback loops, both positive and negative, play intrinsic roles in homeostatic regulation of biological systems. Negative feedback loops underpin the majority of the balances of nature, from predator-prey relationships to biochemical networks, and are clearly subjected to evolutionary pressures <xref ref-type="bibr" rid="pcbi.1002272-Robertson1">[52]</xref>. Negative feedback is a common mode of control for signaling networks <xref ref-type="bibr" rid="pcbi.1002272-Tyson1">[53]</xref>, reducing time required to reach steady states <xref ref-type="bibr" rid="pcbi.1002272-Alon1">[30]</xref>, providing a mechanism for reducing fluctuations in protein expression levels and pathway activity. In contrast to stabilizing activity, in the presence of sufficient time delays, negative feedback can have destabilizing effect and generate overshooting and random oscillations, rendering noise a challenging issue in the modeling of biochemical networks <xref ref-type="bibr" rid="pcbi.1002272-Sun1">[54]</xref>. No attempt was made to incorporate stochasticity into the present investigations. Biological systems employ negative feedback combined with controlled time delays as a means of inducing functional oscillations. Such internally generated oscillations are responsible in large part for circadian rhythms and the cell cycle <xref ref-type="bibr" rid="pcbi.1002272-Novak1">[55]</xref>, which are intimately linked to the subject of feed-fasting cycles in the present work.</p>
        <p>In this work, we have developed a physiological model that simulates selected major components of bioenergetics as outlined in <xref ref-type="bibr" rid="pcbi.1002272-Roden2">[25]</xref>–<xref ref-type="bibr" rid="pcbi.1002272-Balks1">[27]</xref>. The outer general bioenergetics model (outer ring of <xref ref-type="fig" rid="pcbi-1002272-g002">Figure 2</xref>) was created as a “test bed” <xref ref-type="bibr" rid="pcbi.1002272-Ciskowski1">[56]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Zhang1">[57]</xref> for the glycogen circuit, which permits simulation of the glycogen regulatory circuitry in response to physiological changes that mimic the effects of fasting and feeding on whole-body energetics. As we could find no such testbed for the hepatic glycogen regulatory circuit that we were investigating, and as such circuits interact in potentially unpredictable ways with other body systems via the vascular, nervous, and other communication systems, we endeavored to build such a software platform for our investigations. Analysis of this model suggests that the glycogen circuit's context-dependent (fed or fasted) architecture allows for a significant increase in response time when the organism is in a fasted state. Suppression of substrate cycling in the fed state could provide a strategy for energy conservation leading to optimal energy storage.</p>
        <p>The current work also provides a platform for further investigation into bioenergetic diseases such as diabetes and glycogen storage disease (GSD). Type VI and type IX GSD, representing 25–30% of the total cases, are either due to a deficiency in glycogen phosphorylase or an abnormality in the enzyme that activates it <xref ref-type="bibr" rid="pcbi.1002272-Duggan1">[58]</xref>. Therefore, it is crucial to understand glucose-glycogen metabolism in a whole body environment, especially the regulatory mechanisms for some of the key enzymes in these pathways such as glycogen synthase and glycogen phosphorylase. Interestingly, this work could also be of value for research into optimization of nutrition protocols for athletes or soldiers who are required to perform under stress. Glycogen supercompensation, where glycogen storage ability is increased following glycogen depletion when consuming a high carbohydrate diet, is an important issue for performance in athletes. Numerous studies have been carried out to investigate the relationship between the amount and type of carbohydrate ingestion and the maximum glycogen resynthesis rate <xref ref-type="bibr" rid="pcbi.1002272-Costill1">[59]</xref>–<xref ref-type="bibr" rid="pcbi.1002272-Keizer1">[61]</xref>. Of related interest, a study by Roberts et al. <xref ref-type="bibr" rid="pcbi.1002272-Roberts1">[62]</xref> demonstrated that metabolism of simple sugars leads to a higher glycogen resynthesis rate than that generated through the metabolism of complex carbohydrates. Under the current computational model platform, these observations could be further investigated in a continuous parameter space, and an optimal nutrition plan for these individuals might be predicted by taking into account energy flows. Computational models, such as the one developed here, could assist in the design of nutrition plans for athletes and individuals suffering from bioenergetic challenges, including diabetes.</p>
      </sec>
    </sec>
    <sec id="s3" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <p>One of the goals of our metabolic model was to capture key features of the dynamics of internal energy sources, from fed through fasted states, to include blood glucose, liver glycogen, FFAs, and ketone bodies, regulated by plasma glucagon and insulin. The dynamics of these substrates and enzymes are described in <xref ref-type="bibr" rid="pcbi.1002272-Roden2">[25]</xref>–<xref ref-type="bibr" rid="pcbi.1002272-Balks1">[27]</xref>, while the whole body energetics have been reviewed in <xref ref-type="bibr" rid="pcbi.1002272-Cahill1">[26]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Macdonald1">[28]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Frayn1">[29]</xref>. A summary of these time events is given in <xref ref-type="bibr" rid="pcbi.1002272-Murray1">[63]</xref>. Such a simulation would then provide a dynamic framework within which to test the behavior of the underlying control circuitry, as for glycogen in the present study. When the physiological system enters the fasting state, blood glucose concentration drops, flipping a reciprocal switch with respect to plasma insulin and glucagon concentrations <xref ref-type="bibr" rid="pcbi.1002272-Macdonald1">[28]</xref>, <xref ref-type="bibr" rid="pcbi.1002272-Jiang1">[36]</xref>. cAMP then responds and transmits a signal to the glycogen circuitry to regulate the activities of GP and GS <xref ref-type="bibr" rid="pcbi.1002272-Hers1">[7]</xref>. As a result, hepatic glycogen is being depleted as it is catabolized to maintain blood glucose levels within the physiological range needed for survival. The level of plasma free fatty acids and ketone bodies also rise to provide alternative metabolic fuels. A diagram of the concentrations of selected metabolites with respect to time after fasting commences is available in <xref ref-type="fig" rid="pcbi-1002272-g003">Figure 3</xref>. Except for the similar characteristic behaviors described previously in <xref ref-type="bibr" rid="pcbi.1002272-Roden2">[25]</xref>–<xref ref-type="bibr" rid="pcbi.1002272-Frayn1">[29]</xref>, our model is also able to capture the damped oscillations at the beginning of a new local stable state.</p>
      <sec id="s3a">
        <title>Metabolic pathways</title>
        <p>Here we give a brief overview of the four major compartments in our liver-centered physiological model, as shown in <xref ref-type="fig" rid="pcbi-1002272-g002">Figure 2</xref>. For a detailed description of these pathways, model equations and parameters, please refer to <xref ref-type="supplementary-material" rid="pcbi.1002272.s001">Protocol S1</xref>. A detailed parameter-based sensitivity analysis has also been conducted and results revealed that blood glucose is not sensitive to 10-fold changes in the parameters that describe the activity of each enzyme. The results are provided in Table S8–S10 in <xref ref-type="supplementary-material" rid="pcbi.1002272.s001">Protocol S1</xref>.</p>
        <sec id="s3a1">
          <title>Liver</title>
          <p>As a center of bioenergetic regulation, the liver is able to convert glucose that is surplus to immediate energy demands into a short term energy storage form, glycogen, and utilize it to maintain blood glucose homeostasis during the early stages of fasting. Besides its regulatory functions in glycogenesis and glycogenolysis, the liver is also capable of processing amino acids and free fatty acids from muscle and adipose tissue, respectively, to stabilize the blood glucose level when hepatic glycogen is depleted. Recognizing its irreplaceable role in metabolism, the liver is modeled extensively within our physiological network. The eight simplified pathways in the liver include glycolysis, gluconeogenesis, glycogenesis, glycogenolysis, TCA cycle, lipogenesis, lipolysis and ketogenesis.</p>
        </sec>
        <sec id="s3a2">
          <title>Adipose tissue</title>
          <p>As mentioned above, glycogen is a effective short term energy reserve because it can be catabolized quickly to satisfy a urgent need for glucose. In terms of long term energy storage, however, it is not as effective as triglycerides, which is a much more compact energy storage device which is largely contained within adipose tissues. Since our model is focused on the liver's role in metabolism, a brief sketch of the metabolic interactions between this organ and those in the fat and muscle tissue are included in our simulations. An important role of fat is that glucose is taken up by fat in an insulin-dependent manner and is stored as triacylglycerol within fat as an energy depot that is available to drive gluconeogenesis when blood glucose levels drop and glucose generation is needed. The conversion of glucose into and free fatty acids in fat tissue are described in <xref ref-type="supplementary-material" rid="pcbi.1002272.s001">Protocol S1</xref>. The only metabolites modeled for fat tissue are glucose-6-phosphate, acyl-CoA, triacylglycerol and free fatty acids.</p>
        </sec>
        <sec id="s3a3">
          <title>Muscle</title>
          <p>Muscle is another major site for glycogen storage. However, muscle glycogen cannot contribute directly to plasma glucose since muscle lacks glucose-6-phosphatase, an important enzyme in the gluconeogenesis pathway. Instead, the end product of glycolysis, pyruvate, can either form lactate or alanine (our representative for amino acids and proteins), to be transported to the liver. Alanine is a direct substrate for gluconeogenesis in liver while lactate assists in the maintenance blood glucose level through the Cori cycle, in which lactate is used in gluconeogenesis in liver. In our model, muscle is modeled as a sink term for metabolic fuels such as glucose and ketone bodies and also an alternative energy source to provide lactate and alanine. The metabolites modeled for muscle are glycogen, glucose-6-phosphate, pyruvate, lactate, alanine and ketone bodies.</p>
        </sec>
        <sec id="s3a4">
          <title>Blood</title>
          <p>For simplification, all the metabolic processes (except for degradation) are ignored in the blood. It only serves as a transport system, conveying nutrients between the major organs simulated by the model.</p>
          <p>All the transport processes described above are shown in Figure S4 in <xref ref-type="supplementary-material" rid="pcbi.1002272.s001">Protocol S1</xref> and a more detailed description is also provided there.</p>
        </sec>
      </sec>
    </sec>
    <sec id="s4">
      <title>Supporting Information</title>
      <supplementary-material id="pcbi.1002272.s001" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.s001" xlink:type="simple">
        <label>Protocol S1</label>
        <caption>
          <p>Detailed model equations and supplemental figures.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002272.s002" mimetype="application/x-rar-compressed" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.s002" xlink:type="simple">
        <label>Protocol S2</label>
        <caption>
          <p>MATLAB Package.</p>
          <p>(RAR)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002272.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.s003" xlink:type="simple">
        <label>Protocol S3</label>
        <caption>
          <p>Readme file for the MATLAB package.</p>
          <p>(DOCX)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002272.s004" mimetype="text/xml" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002272.s004" xlink:type="simple">
        <label>Protocol S4</label>
        <caption>
          <p>SBML version of the MATLAB package.</p>
          <p>(XML)</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pcbi.1002272-Devlin1">
        <label>1</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Devlin</surname><given-names>TM</given-names></name></person-group>             <year>2010</year>             <source>Textbook of biochemistry with clinical correlations</source>             <publisher-loc>New Jersey</publisher-loc>             <publisher-name>Wiley-Liss</publisher-name>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Parsons1">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Parsons</surname><given-names>PA</given-names></name></person-group>             <year>2005</year>             <article-title>Environments and evolution: interactions between stress, resource inadequacy and energetic efficiency.</article-title>             <source>Biol Rev Cambridge Philos Soc</source>             <volume>80</volume>             <fpage>589</fpage>             <lpage>610</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Pardridge1">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Pardridge</surname><given-names>WM</given-names></name><name name-style="western"><surname>Jefferson</surname><given-names>LS</given-names></name></person-group>             <year>1975</year>             <article-title>Liver uptake of amino acids and carbohydrates during a single circulatory passage.</article-title>             <source>Am J Physiol</source>             <volume>228</volume>             <fpage>1155</fpage>             <lpage>1161</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Otter1">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Otter</surname><given-names>W</given-names></name><name name-style="western"><surname>Boxtel</surname><given-names>ABTG</given-names></name></person-group>             <year>1971</year>             <article-title>Relation between the glycogen content of the liver and liver weight, and its meaning for enzymology.</article-title>             <source>Cell Mol Life Sci</source>             <volume>27</volume>             <fpage>1271</fpage>             <lpage>1272</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Bonjorn1">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bonjorn</surname><given-names>VM</given-names></name><name name-style="western"><surname>Latour</surname><given-names>MG</given-names></name><name name-style="western"><surname>Bèlanger</surname><given-names>P</given-names></name><name name-style="western"><surname>Lavoie</surname><given-names>JM</given-names></name></person-group>             <year>2002</year>             <article-title>Inuence of prior exercise and liver glycogen content on the sensitivity of the liver to glucagon.</article-title>             <source>J Appl Physiol</source>             <volume>92</volume>             <fpage>188</fpage>             <lpage>194</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Roach1">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Roach</surname><given-names>P</given-names></name></person-group>             <year>2002</year>             <article-title>Glycogen and its metabolism.</article-title>             <source>Curr Mol Med</source>             <volume>2</volume>             <fpage>101</fpage>             <lpage>120</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Hers1">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hers</surname><given-names>H</given-names></name></person-group>             <year>1976</year>             <article-title>The control of glycogen metabolism in the liver.</article-title>             <source>Annu Rev Biochem</source>             <volume>45</volume>             <fpage>167</fpage>             <lpage>189</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Greenberg1">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Greenberg</surname><given-names>C</given-names></name><name name-style="western"><surname>Jurczak</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Danos</surname><given-names>AM</given-names></name><name name-style="western"><surname>Brady</surname><given-names>MJ</given-names></name></person-group>             <year>2006</year>             <article-title>Glycogen branches out: new perspectives on the role of glycogen metabolism in the integration of metabolic pathways.</article-title>             <source>Am J Physiol Endocrinol Metab</source>             <volume>291</volume>             <fpage>E1</fpage>             <lpage>E8</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Roden1">
        <label>9</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Roden</surname><given-names>M</given-names></name></person-group>             <year>2007</year>             <source>Clinical diabetes research: methods and techniques</source>             <publisher-loc>Chiehester</publisher-loc>             <publisher-name>Wiley- Interscience</publisher-name> <!--===== Restructure page-count as size[@units="page"] =====--><size units="page">145</size>           </element-citation>
      </ref>
      <ref id="pcbi.1002272-Hers2">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hers</surname><given-names>HG</given-names></name><name name-style="western"><surname>Hue</surname><given-names>L</given-names></name></person-group>             <year>1983</year>             <article-title>Gluconeogenesis and related aspects of glycolysis.</article-title>             <source>Annu Rev Biochem</source>             <volume>52</volume>             <fpage>617</fpage>             <lpage>653</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Aishwarya1">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Aishwarya</surname><given-names>K</given-names></name><name name-style="western"><surname>Rachana</surname><given-names>K</given-names></name><name name-style="western"><surname>Prakash</surname><given-names>ES</given-names></name></person-group>             <year>2005</year>             <article-title>Futile cycling in physiologic control systems: a price paid for fine control.</article-title>             <source>Adv Physiol Educ</source>             <volume>29</volume>             <fpage>132</fpage>             <lpage>135</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Newsholme1">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Newsholme</surname><given-names>EA</given-names></name><name name-style="western"><surname>Challissa</surname><given-names>RAJ</given-names></name><name name-style="western"><surname>Crabtreeb</surname><given-names>B</given-names></name></person-group>             <year>1984</year>             <article-title>Substrate cycles: their role in improving sensitivity in metabolic control.</article-title>             <source>Trends Biochem Sci</source>             <volume>9</volume>             <fpage>277</fpage>             <lpage>280</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Chao1">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chao</surname><given-names>YP</given-names></name><name name-style="western"><surname>Liao</surname><given-names>JC</given-names></name></person-group>             <year>1994</year>             <article-title>Metabolic responses to substrate futile cycling in escherichia coli.</article-title>             <source>J Biol Chem</source>             <volume>269</volume>             <fpage>5122</fpage>             <lpage>5126</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-deGraaf1">
        <label>14</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>de Graaf</surname><given-names>AA</given-names></name><name name-style="western"><surname>Freidig</surname><given-names>AP</given-names></name><name name-style="western"><surname>De Roos</surname><given-names>B</given-names></name><name name-style="western"><surname>Jamshidi</surname><given-names>N</given-names></name><name name-style="western"><surname>Heinemann</surname><given-names>M</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Nutritional systems biology modeling: from molecular mechanisms to physiology.</article-title>             <source>PLoS Comput Biol</source>             <volume>5</volume>             <fpage>e1000554</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Hall1">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>KD</given-names></name></person-group>             <year>2009</year>             <article-title>Predicting metabolic adaptation, body weight change, and energy intake in humans.</article-title>             <source>Am J Physiol Endocrinol Metab</source>             <volume>298</volume>             <fpage>E449</fpage>             <lpage>E466</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Gastin1">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gastin</surname><given-names>PB</given-names></name></person-group>             <year>2001</year>             <article-title>Energy system interaction and relative contribution during maximal exercise.</article-title>             <source>Sports Med</source>             <volume>31</volume>             <fpage>725</fpage>             <lpage>741</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Duarte1">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Duarte</surname><given-names>N</given-names></name><name name-style="western"><surname>Becker</surname><given-names>S</given-names></name><name name-style="western"><surname>Jamshidi</surname><given-names>N</given-names></name><name name-style="western"><surname>Thiele</surname><given-names>I</given-names></name><name name-style="western"><surname>Mo</surname><given-names>M</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Global reconstruction of the human metabolic network based on genomic and bibliomic data.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>104</volume>             <fpage>1777</fpage>             <lpage>1782</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Gille1">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gille</surname><given-names>C</given-names></name><name name-style="western"><surname>Bölling</surname><given-names>C</given-names></name><name name-style="western"><surname>Hoppe</surname><given-names>A</given-names></name><name name-style="western"><surname>Bulik</surname><given-names>S</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>S</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Hepatonet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology.</article-title>             <source>Mol Syst Biol</source>             <volume>6</volume>             <fpage>411</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Jerby1">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jerby</surname><given-names>L</given-names></name><name name-style="western"><surname>Shlomi</surname><given-names>T</given-names></name><name name-style="western"><surname>Ruppin</surname><given-names>E</given-names></name></person-group>             <year>2010</year>             <article-title>Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism.</article-title>             <source>Mol Syst Biol</source>             <volume>6</volume>             <fpage>401</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Ma1">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>H</given-names></name><name name-style="western"><surname>Sorokin</surname><given-names>A</given-names></name><name name-style="western"><surname>Mazein</surname><given-names>A</given-names></name><name name-style="western"><surname>Selkov</surname><given-names>A</given-names></name><name name-style="western"><surname>Selkov</surname><given-names>E</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>The edinburgh human metabolic network reconstruction and its functional analysis.</article-title>             <source>Mol Syst Biol</source>             <volume>3</volume>             <fpage>135</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Maier1">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Maier</surname><given-names>K</given-names></name><name name-style="western"><surname>Hofmann</surname><given-names>U</given-names></name><name name-style="western"><surname>Reuss</surname><given-names>M</given-names></name><name name-style="western"><surname>Mauch</surname><given-names>K</given-names></name></person-group>             <year>2010</year>             <article-title>Dynamics and control of the central carbon metabolism in hepatoma cells.</article-title>             <source>BMC Syst Biol</source>             <volume>4</volume>             <fpage>54</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Edwards1">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>J</given-names></name><name name-style="western"><surname>Ibarra</surname><given-names>R</given-names></name><name name-style="western"><surname>Palsson</surname><given-names>BØ</given-names></name></person-group>             <year>2001</year>             <article-title>In silico predictions of escherichia coli metabolic capabilities are consistent with experimental data.</article-title>             <source>Nat Biotechnol</source>             <volume>19</volume>             <fpage>125</fpage>             <lpage>130</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Orth1">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Orth</surname><given-names>J</given-names></name><name name-style="western"><surname>Thiele</surname><given-names>I</given-names></name><name name-style="western"><surname>Palsson</surname><given-names>BØ</given-names></name></person-group>             <year>2010</year>             <article-title>What is ux balance analysis?</article-title>             <source>Nat Biotechnol</source>             <volume>28</volume>             <fpage>245</fpage>             <lpage>248</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Mutalik1">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mutalik</surname><given-names>V</given-names></name><name name-style="western"><surname>Venkatesh</surname><given-names>K</given-names></name></person-group>             <year>2005</year>             <article-title>Quantification of the glycogen cascade system: the ultrasensitive responses of liver glycogen synthase and muscle phosphorylase are due to distinctive regulatory designs.</article-title>             <source>Theor Biol Med Modell</source>             <volume>2</volume>             <fpage>19</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Roden2">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Roden</surname><given-names>M</given-names></name><name name-style="western"><surname>Bernroider</surname><given-names>E</given-names></name></person-group>             <year>2003</year>             <article-title>Hepatic glucose metabolism in humansits role in health and disease.</article-title>             <source>Best Pract Res Clin Endocrinol Metab</source>             <volume>17</volume>             <fpage>365</fpage>             <lpage>383</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Cahill1">
        <label>26</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Cahill</surname><given-names>GJ</given-names></name></person-group>             <year>2006</year>             <article-title>Fuel metabolism in starvation.</article-title>             <source>Annu Rev Nutr</source>             <volume>26</volume>             <fpage>1</fpage>             <lpage>22</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Balks1">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Balks</surname><given-names>H</given-names></name><name name-style="western"><surname>Jungermann</surname><given-names>K</given-names></name></person-group>             <year>1984</year>             <article-title>Regulation of peripheral insulin/glucagon levels by rat liver.</article-title>             <source>Eur J Biochem</source>             <volume>141</volume>             <fpage>645</fpage>             <lpage>650</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Macdonald1">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Macdonald</surname><given-names>IA</given-names></name><name name-style="western"><surname>Webber</surname><given-names>J</given-names></name></person-group>             <year>1995</year>             <article-title>Feeding, fasting and starvation: factors affecting fuel utilization.</article-title>             <source>Proc Nutr Soc</source>             <volume>54</volume>             <fpage>267</fpage>             <lpage>274</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Frayn1">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Frayn</surname><given-names>KN</given-names></name></person-group>             <year>1997</year>             <article-title>Integration of substrate ow in vivo: some insights into metabolic control.</article-title>             <source>Clin Nutr</source>             <volume>16</volume>             <fpage>277</fpage>             <lpage>282</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Alon1">
        <label>30</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Alon</surname><given-names>U</given-names></name></person-group>             <year>2007</year>             <source>An Introduction to Systems Biology: Design Principles of Biological Circuits</source>             <publisher-loc>Florida</publisher-loc>             <publisher-name>Chapman &amp; Hall/CRC</publisher-name>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Mangan1">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mangan</surname><given-names>S</given-names></name><name name-style="western"><surname>Alon</surname><given-names>U</given-names></name></person-group>             <year>2003</year>             <article-title>Structure and function of the feed-forward loop network motif.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>100</volume>             <fpage>11980</fpage>             <lpage>11985</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Alon2">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Alon</surname><given-names>U</given-names></name></person-group>             <year>2003</year>             <article-title>Biological networks: The tinkerer as an engineer.</article-title>             <source>Science</source>             <volume>301</volume>             <fpage>1866</fpage>             <lpage>1867</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Lahav1">
        <label>33</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lahav</surname><given-names>G</given-names></name><name name-style="western"><surname>Rosenfeld</surname><given-names>N</given-names></name><name name-style="western"><surname>Sigal</surname><given-names>A</given-names></name><name name-style="western"><surname>Geva-Zatorsky</surname><given-names>N</given-names></name><name name-style="western"><surname>Levine</surname><given-names>AJ</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Dynamics of the p53- mdm2 feedback loop in individual cells.</article-title>             <source>Nat Genet</source>             <volume>36</volume>             <fpage>147</fpage>             <lpage>150</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Klover1">
        <label>34</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Klover</surname><given-names>P</given-names></name><name name-style="western"><surname>Mooney</surname><given-names>RA</given-names></name></person-group>             <year>2004</year>             <article-title>Hepatocytes: critical for glucose homeostasis.</article-title>             <source>Int J Biochem Cell Biol</source>             <volume>36</volume>             <fpage>753</fpage>             <lpage>758</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Khan1">
        <label>35</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>K</given-names></name><name name-style="western"><surname>Pessin</surname><given-names>J</given-names></name></person-group>             <year>2002</year>             <article-title>Insulin regulation of glucose uptake: a complex interplay of intracellular signaling pathways.</article-title>             <source>Diabetologia</source>             <volume>45</volume>             <fpage>1475</fpage>             <lpage>1483</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Jiang1">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>BB</given-names></name></person-group>             <year>2003</year>             <article-title>Glucagon and regulation of glucose metabolism.</article-title>             <source>Am J Physiol Endocrinol Metab</source>             <volume>284</volume>             <fpage>E671</fpage>             <lpage>E678</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Dohm1">
        <label>37</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dohm</surname><given-names>GL</given-names></name><name name-style="western"><surname>Tapscott</surname><given-names>EB</given-names></name><name name-style="western"><surname>Barakat</surname><given-names>HA</given-names></name><name name-style="western"><surname>Kasperek</surname><given-names>GJ</given-names></name></person-group>             <year>1983</year>             <article-title>Inuence of fasting on glycogen depletion in rats during exercise.</article-title>             <source>J Appl Physiol</source>             <volume>55</volume>             <fpage>830</fpage>             <lpage>833</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Wijk1">
        <label>38</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wijk</surname><given-names>R</given-names></name><name name-style="western"><surname>Solinge</surname><given-names>WW</given-names></name></person-group>             <year>2003</year>             <article-title>The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis.</article-title>             <source>Blood</source>             <volume>106</volume>             <fpage>4034</fpage>             <lpage>4042</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Magistretti1">
        <label>39</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Magistretti</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Pellerin</surname><given-names>L</given-names></name></person-group>             <year>1996</year>             <article-title>Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes.</article-title>             <source>Cereb Cortex</source>             <volume>6</volume>             <fpage>50</fpage>             <lpage>61</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Stalmans1">
        <label>40</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Stalmans</surname><given-names>W</given-names></name><name name-style="western"><surname>Wulf</surname><given-names>H</given-names></name><name name-style="western"><surname>Hue</surname><given-names>L</given-names></name><name name-style="western"><surname>Hers</surname><given-names>H</given-names></name></person-group>             <year>1974</year>             <article-title>The sequential inactivation of glycogen phosphorylase and activation of glycogen synthetase in liver after the administration of glucose to mice and rats.</article-title>             <source>Eur J Biochem</source>             <volume>41</volume>             <fpage>117</fpage>             <lpage>134</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Massillon1">
        <label>41</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Massillon</surname><given-names>D</given-names></name><name name-style="western"><surname>Bollen</surname><given-names>M</given-names></name><name name-style="western"><surname>Wulf</surname><given-names>H</given-names></name><name name-style="western"><surname>Overloop</surname><given-names>K</given-names></name><name name-style="western"><surname>Vanstapel</surname><given-names>F</given-names></name><etal/></person-group>             <year>1995</year>             <article-title>Demonstration of a glycogen/glucose-1-phosphate cycle in hepatocytes from fasted rats.</article-title>             <source>J Biol Chem</source>             <volume>270</volume>             <fpage>19351</fpage>             <lpage>19356</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Mvumbi1">
        <label>42</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mvumbi</surname><given-names>L</given-names></name><name name-style="western"><surname>Stalmans</surname><given-names>W</given-names></name></person-group>             <year>1987</year>             <article-title>High-affinity binding of glycogen-synthase phosphatase to glycogen particles in liver.</article-title>             <source>Biochem J</source>             <volume>246</volume>             <fpage>367</fpage>             <lpage>374</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Todd1">
        <label>43</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Todd</surname><given-names>A</given-names></name></person-group>             <year>2008</year>             <source>Inclusion of a glycogen regulation mathematical model into a contextual metabolic framework [Ph.D. thesis]</source>             <publisher-loc>Chapel Hill (North Carolina)</publisher-loc>             <publisher-name>University of North Carolina at Chapel Hill</publisher-name>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Kelsall1">
        <label>44</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kelsall</surname><given-names>IR</given-names></name><name name-style="western"><surname>Rosenzweig</surname><given-names>D</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>P</given-names></name></person-group>             <year>2009</year>             <article-title>Disruption of the allosteric phosphorylase a regulation of the hepatic glycogen-targeted protein phosphatase 1 improves glucose tolerance in vivo.</article-title>             <source>Cell Signalling</source>             <volume>21</volume>             <fpage>1123</fpage>             <lpage>1134</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Andrikopoulos1">
        <label>45</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Andrikopoulos</surname><given-names>S</given-names></name><name name-style="western"><surname>Blair</surname><given-names>AR</given-names></name><name name-style="western"><surname>Deluca</surname><given-names>N</given-names></name><name name-style="western"><surname>Fam</surname><given-names>BC</given-names></name><name name-style="western"><surname>Proietto</surname><given-names>J</given-names></name></person-group>             <year>2008</year>             <article-title>Evaluating the glucose tolerance test in mice.</article-title>             <source>Am J Physiol Endocrinol Metab</source>             <volume>295</volume>             <fpage>E1323</fpage>             <lpage>E1332</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Klueh1">
        <label>46</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Klueh</surname><given-names>U</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cho</surname><given-names>B</given-names></name><name name-style="western"><surname>Ouyang</surname><given-names>T</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>B</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Continuous glucose monitoring in normal mice and mice with prediabetes and diabetes.</article-title>             <source>Diabetes Technol Ther</source>             <volume>8</volume>             <fpage>402</fpage>             <lpage>412</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Watts1">
        <label>47</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Watts</surname><given-names>C</given-names></name><name name-style="western"><surname>Malthus</surname><given-names>RS</given-names></name></person-group>             <year>1980</year>             <article-title>Liver glycogen synthase in rats with a glycogen-storage disorder.</article-title>             <source>Eur J Biochem</source>             <volume>108</volume>             <fpage>73</fpage>             <lpage>77</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Armstrong1">
        <label>48</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Armstrong</surname><given-names>CG</given-names></name><name name-style="western"><surname>Doherty</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>PTW</given-names></name></person-group>             <year>1998</year>             <article-title>Identification of the separate domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 that interact with phosphorylase a, glycogen and protein phosphatase 1.</article-title>             <source>Biochem J</source>             <volume>336</volume>             <fpage>699</fpage>             <lpage>704</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Hue1">
        <label>49</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hue</surname><given-names>L</given-names></name><name name-style="western"><surname>Bontemps</surname><given-names>F</given-names></name><name name-style="western"><surname>Hers</surname><given-names>H</given-names></name></person-group>             <year>1975</year>             <article-title>The effect of glucose and of potassium ions on the interconversion of the two forms of glycogen phosphorylase and of glycogen synthetase in isolated rat liver preparations.</article-title>             <source>Biochem J</source>             <volume>152</volume>             <fpage>105</fpage>             <lpage>114</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Cortassa1">
        <label>50</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Cortassa</surname><given-names>S</given-names></name><name name-style="western"><surname>ORourke</surname><given-names>B</given-names></name><name name-style="western"><surname>L</surname><given-names>WR</given-names></name><name name-style="western"><surname>Aon</surname><given-names>MA</given-names></name></person-group>             <year>2009</year>             <article-title>Control and regulation of integrated mitochondrial function in metabolic and transport networks.</article-title>             <source>Int J Mol Sci</source>             <volume>10</volume>             <fpage>1500</fpage>             <lpage>1513</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-LeDuc1">
        <label>51</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>LeDuc</surname><given-names>PR</given-names></name><name name-style="western"><surname>Messner</surname><given-names>WC</given-names></name><name name-style="western"><surname>Wikswo</surname><given-names>JP</given-names></name></person-group>             <year>2011</year>             <article-title>How do control-based approaches enter into biology?</article-title>             <source>Annu Rev Biomed Eng</source>             <volume>13</volume>             <fpage>369</fpage>             <lpage>396</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Robertson1">
        <label>52</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Robertson</surname><given-names>DS</given-names></name></person-group>             <year>1991</year>             <article-title>Feedback theory and darwinian evolution.</article-title>             <source>J Theor Biol</source>             <volume>152</volume>             <fpage>469</fpage>             <lpage>484</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Tyson1">
        <label>53</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tyson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Novak</surname><given-names>B</given-names></name></person-group>             <year>2001</year>             <article-title>Network dynamics and cell physiology.</article-title>             <source>Nat Rev Mol Cell Biol</source>             <volume>2</volume>             <fpage>908</fpage>             <lpage>916</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Sun1">
        <label>54</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><name name-style="western"><surname>Becskei</surname><given-names>A</given-names></name></person-group>             <year>2010</year>             <article-title>Systems biology: The cost of feedback control.</article-title>             <source>Nature</source>             <volume>467</volume>             <fpage>163</fpage>             <lpage>164</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Novak1">
        <label>55</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Novak</surname><given-names>B</given-names></name><name name-style="western"><surname>Tyson</surname><given-names>JJ</given-names></name></person-group>             <year>2008</year>             <article-title>Design principles of biochemical oscillators.</article-title>             <source>Nat Rev Mol Cell Biol</source>             <volume>9</volume>             <fpage>981</fpage>             <lpage>991</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Ciskowski1">
        <label>56</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ciskowski</surname><given-names>MA</given-names></name><name name-style="western"><surname>Overland</surname><given-names>D</given-names></name></person-group>             <year>2006</year>             <article-title>Process control for advanced life support, biological test bed.</article-title>             <source>Int Conf Environ Syst</source>             <comment>2006-01-2124</comment>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Zhang1">
        <label>57</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Hoo</surname><given-names>KA</given-names></name></person-group>             <year>2005</year>             <article-title>Modeling and control studies of an integrated biological wastewater treatment system.</article-title>             <source>Int Conf Environ Syst</source>             <comment>2005-01-2963</comment>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Duggan1">
        <label>58</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Duggan</surname><given-names>C</given-names></name><name name-style="western"><surname>Watkins</surname><given-names>J</given-names></name><name name-style="western"><surname>Walker</surname><given-names>W</given-names></name></person-group>             <year>2008</year>             <source>Nutrition in pediatrics: basic science, clinical applications</source>             <publisher-loc>Ontario</publisher-loc>             <publisher-name>BC Decker Inc. </publisher-name> <!--===== Restructure page-count as size[@units="page"] =====--><size units="page">511</size>           </element-citation>
      </ref>
      <ref id="pcbi.1002272-Costill1">
        <label>59</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Costill</surname><given-names>D</given-names></name><name name-style="western"><surname>Sherman</surname><given-names>W</given-names></name><name name-style="western"><surname>Gind</surname><given-names>C</given-names></name><name name-style="western"><surname>Maresh</surname><given-names>C</given-names></name><name name-style="western"><surname>Witten</surname><given-names>M</given-names></name><etal/></person-group>             <year>1981</year>             <article-title>The role of dietary carbohydrate in muscle glycogen resynthesis after strenuous exercise.</article-title>             <source>Am J Clin Nutr</source>             <volume>34</volume>             <fpage>1831</fpage>             <lpage>1836</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Blom1">
        <label>60</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Blom</surname><given-names>P</given-names></name><name name-style="western"><surname>Hostmark</surname><given-names>A</given-names></name><name name-style="western"><surname>Baage</surname><given-names>O</given-names></name><name name-style="western"><surname>Kardel</surname><given-names>K</given-names></name><name name-style="western"><surname>Machlum</surname><given-names>S</given-names></name></person-group>             <year>1987</year>             <article-title>Effect of different post-exercise sugar diets on the rate of muscle glycogen synthesis.</article-title>             <source>Med Sci Sports Exerc</source>             <volume>19</volume>             <fpage>491</fpage>             <lpage>496</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Keizer1">
        <label>61</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Keizer</surname><given-names>H</given-names></name><name name-style="western"><surname>Kuipers</surname><given-names>H</given-names></name><name name-style="western"><surname>Van Kranenburg</surname><given-names>G</given-names></name><name name-style="western"><surname>Geurten</surname><given-names>P</given-names></name></person-group>             <year>1987</year>             <article-title>Inuence of liquid and solid meals on muscle glycogen resynthesis, plasma fuel hormone response and maximal physical working capacity.</article-title>             <source>Int J Sports Med</source>             <volume>8</volume>             <fpage>99</fpage>             <lpage>101</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Roberts1">
        <label>62</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>A</given-names></name><name name-style="western"><surname>Noble</surname><given-names>D</given-names></name><name name-style="western"><surname>Hayden</surname><given-names>D</given-names></name><name name-style="western"><surname>Talyor</surname><given-names>A</given-names></name></person-group>             <year>1988</year>             <article-title>Simple and complex carbohydrate-rich diets and muscle glycogen content of marathon runners.</article-title>             <source>Eur J Appl Physiol</source>             <volume>57</volume>             <fpage>70</fpage>             <lpage>74</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002272-Murray1">
        <label>63</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Murray</surname><given-names>RK</given-names></name><name name-style="western"><surname>Bender</surname><given-names>DA</given-names></name><name name-style="western"><surname>Botham</surname><given-names>KM</given-names></name><name name-style="western"><surname>Kennelly</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Rodwell</surname><given-names>VW</given-names></name><etal/></person-group>             <year>2009</year>             <source>Harper's illustrated biochemistry</source>             <publisher-loc>New Jersey</publisher-loc>             <publisher-name>The McGraw-Hill Medical, 28th edition</publisher-name> <!--===== Restructure page-count as size[@units="page"] =====--><size units="page">140</size>           </element-citation>
      </ref>
    </ref-list>
    
  </back>
</article>